Nektar Therapeutics (NKTR) Inventory Average (2011 - 2024)

Nektar Therapeutics' Inventory Average history runs 14 years deep, the most recent figure standing at $15.4 million for Q2 2024.

• In Q2 2024, Inventory Average fell 24.98% year-over-year to $15.4 million; the TTM figure through Jun 2024 stood at $15.4 million (down 24.98% YoY), while the FY2023 annual figure was $17.7 million, up 0.86% from the prior year.
• Inventory Average for Q2 2024 stood at $15.4 million, down from $16.2 million in the prior quarter.
• The five-year high for Inventory Average was $20.5 million in Q2 2023, with the low at $12.7 million in Q3 2020.
• The 5-year median for Inventory Average is $15.7 million (2021), against an average of $16.1 million.
• The sharpest annual moves came in 2023 and 2024: Inventory Average increased 26.51% in 2023, then retreated 24.98% in 2024.
• Nektar Therapeutics' Inventory Average stood at $14.1 million in 2020, then climbed by 10.46% to $15.6 million in 2021, then gained by 22.9% to $19.1 million in 2022, then dropped by 18.37% to $15.6 million in 2023, then slipped by 1.69% to $15.4 million in 2024.
• Business Quant data shows NKTR's Inventory Average at $15.4 million in Q2 2024, $16.2 million in Q1 2024, and $15.6 million in Q4 2023.